#2021435
Rineatraicéíteas tógálach buaibheach/bált-fhaighníteas puchóideach ionfhabhtaíoch (IBR/IPV)
Infectious bovine rhinotracheitis/infectious pustular vulvovaginitis (IBR/IPV)
Filter results
Collections
18 results in 3 documents
#2021648
RINEATRAICÉÍTEAS TÓGÁLACH BUAIBHEACH/BÁLT-FHAIGHNÍTEAS PUCHÓIDEACH IONFHABHTAÍOCH (IBR/IPV)
INFECTIOUS BOVINE RHINOTRACHEITIS/INFECTIOUS PUSTULAR VULVOVAGINITIS (IBR/IPV)
#2021649
Ballstáit nó criosanna díobh ag a bhfuil stádas saor ó ghalair maidir le IBR/IPV
Member States or zones thereof with disease-free status from IBR/IPV
#2021650
Ballstáit nó criosanna díobh ag a bhfuil clár díothaithe formheasta maidir le IBR/IPV
Member States or zones thereof with an approved eradication programme for IBR/IPV
#2861546
an líon bunaíochtaí a tástáladh le haghaidh IBR/IPV gach bliain le 3 bliana anuas;
number of establishments tested for IBR/IPV each year for the last three years;
#2861547
an líon bunaíochtaí a deimhníodh go bhfuil siad ionfhabhtaithe le IBR/IPV gach bliain le 3 bliana anuas;
number of establishments confirmed infected with IBR/IPV each year for the last three years;
#2861548
dáta an toirmisc ar vacsaíniú i gcoinne IBR/IPV i ndáil le bó-ainmhithe ar coimeád;
date of prohibition of vaccination against IBR/IPV of kept bovine animals;
#2021394
I gCinneadh 2004/558/CE ón gCoimisiún, leagtar amach na liostaí de réigiúin na mBallstát a bhfuil stádas saor ó IBR acu agus de réigiúin na mBallstát a bhfuil clár dhíothú IBR formheasta acu i gcomhréir le Treoir 64/432/CEE.
Commission Decision 2004/558/EC sets out the lists of regions of Member States that have the IBR-free status and the regions of Member States that have an approved IBR eradication programme in accordance with Directive 64/432/EEC.
#2021395
Ba cheart na réigiúin a bhfuil stádas saor ó IBR acu a liostú go cuí sna hIarscríbhinní a ghabhann leis an Rialachán seo, agus ba cheart do na réigiúin sin a bhfuil cláir dhíothú IBR fhormheasta acu a gclár a choinneáil ar bun go ceann tréimhse theoranta ama i gcomhréir le Rialachán (AE) 2020/689, agus ba cheart iad a liostú sna hIarscríbhinní a ghabhann leis an Rialachán seo.
The regions with IBR-free status should be duly listed in the Annexes to this Regulation, whereas the regions with approved IBR eradication programmes should maintain their programme for a limited period of time in accordance with Regulation (EU) 2020/689, and should be listed in the Annexes to this Regulation.
#2021436
Déanfar na Ballstáit nó criosanna díobh ag a bhfuil stádas saor ó ghalair maidir le rineatraicéíteas tógálach buaibheach/bált-fhaighníteas puchóideach ionfhabhtaíoch (IBR/IPV) a liostú i gCuid I d’Iarscríbhinn V.
The Member States or zones thereof with disease-free status from infectious bovine rinotracheitis/infectious pustular vulvovaginitis (IBR/IPV) shall be listed in Part I of Annex V.
#2021437
Déanfar na Ballstáit nó criosanna díobh ag a bhfuil clár díothaithe roghnach formheasta maidir le IBR/IPV a liostú i gCuid II d’Iarscríbhinn V.
The Member States or zones thereof with an approved optional eradication programme for IBR/IPV shall be listed in Part II of Annex V.
#2831584
Maidir le IBR/IPV, tá iarratas curtha faoi bhráid an Choimisiúin ag an tSlóvaic chun clár díothaithe roghnach a fhormheas le haghaidh crios a chuimsíonn réigiúin na Bratasláive, Košice, Prešov, Trnava agus Žilina.
For IBR/IPV, Slovakia has submitted to the Commission an application to have an optional eradication programme approved for a zone comprising the regions of Bratislava, Košice, Prešov, Trnava and Žilina.
#2831586
Dá bhrí sin, ba cheart an crios sin a liostú i gCuid II d’Iarscríbhinn V a ghabhann le Rialachán Cur Chun Feidhme (AE) 2021/620, mar chrios a bhfuil clár díothaithe formheasta aige le haghaidh IBR/IPV.
Therefore, that zone should be listed in Part II of Annex V to Implementing Regulation (EU) 2021/620, as a zone with an approved eradication programme for IBR/IPV.
#2861544
i gcás cláir dhíothaithe le haghaidh IBR/IPV, de réir an chreasa, má tá níos mó ná crios amháin san áireamh i raon feidhme críochach an chláir:
in the case of eradication programmes for IBR/IPV, by zone, if more than one zone is included in the territorial scope of the programme:
#2861545
an líon bunaíochtaí a bhfuil an stádas saor ó LBE acu lena n-áirítear bunaíochtaí a bhfuil stádas saor ó ghalar ar fionraí acu amhail an 31 Nollaig gach bliain le 3 bliana anuas;
number of establishments with the status free from IBR/IPV including establishments with suspended disease-free status at 31 December of each year for the last three years;
#2021360
I Rialachán (AE) 2016/429 meastar gur galair liostaithe na galair seo a leanas: ionfhabhtú le Brucella abortus, B. melitensis agus B. suis, ionfhabhtú le coimpléasc Mycobacterium tuberculosis (MTBC), ionfhabhtú le víreas an chonfaidh (RABV), liúcóis bhuaibheach eansótach (LBE), ionfhabhtú leis an víreas gormtheanga (séiritíopaí 1-24) (ionfhabhtú le BTV), buinneach víreasach bhólachta (BVB), rineatraicéíteas tógálach buaibheach/bált-fhaighníteas puchóideach ionfhabhtaíoch (IBR/IPV), ionfhabhtú le víreas ghalar Aujeszky (ADV), fíniú le Varroa spp., ionfhabhtú le víreas ghalar Newcastle, ionfhabhtú le fliú éanúil ardphataigineach (HPAI), seipticéime fuilreatha víreasach (VHS), neacróis fhuilghinte ionfhabhtaíoch (IHN), ionfhabhtú le víreas ainéime ionfhabhtaíoch na mbradán atá scriosta sa réigiún ardpholamorfach (ISAV HPR-scriosta), ionfhabhtú le Marteilia refringens, ionfhabhtú le Bonamia exitiosa, ionfhabhtú le Bonamia ostreae, agus ionfhabhtú le víreas na spotaí bána (WSSV).
Regulation (EU) 2016/429 regards the following as listed diseases: infection with Brucella abortus, B. melitensis and B. suis, infection with Mycobacterium tuberculosis complex (MTBC), infection with rabies virus (RABV), enzootic bovine leucosis (EBL), infection with bluetongue virus (serotypes 1-24) (infection with BTV), bovine viral diarrhoea (BVD), infectious bovine rinotracheitis/infectious pustular vulvovaginitis (IBR/IPV), infection with Aujeszky’s disease virus (ADV), infestation with Varroa spp., infection with Newcastle disease virus, infection with highly pathogenic avian influenza (HPAI), viral haemorrhagic septicaemia (VHS), infectious haematopoietic necrosis (IHN), infection with highly polymorphic region deleted infectious salmon anaemia virus (HPR-deleted ISAV), infection with Marteilia refringens, infection with Bonamia exitiosa, infection with Bonamia ostreae, and infection with white spot syndrome virus (WSSV).
#2831571
Maidir le hionfhabhtú le Brucella abortus, B. melitensis agus B. suis, ionfhabhtú le coimpléasc Mycobacterium tuberculosis (Mycobacterium bovis, M. caprae agus M. tuberculosis) (MTBC), ionfhabhtú le víreas an chonfaidh (RABV), liúcóis bhuaibheach eansótach (LBE), rineatraicéíteas tógálach buaibheach/bált-fhaighníteas puchóideach ionfhabhtaíoch (IBR/IPV), ionfhabhtú le víreas ghalar Aujeszky (ADV), buinneach víreasach bhuaibheach (BVB) agus ionfhabhtú leis an víreas gormtheanga (séiritíopaí 1-24) (BTV), tá iarratas curtha isteach ag roinnt Ballstát chuig an gCoimisiún le déanaí maidir le stádas saor ó ghalair a dheonú orthu nó cláir dhíothaithe éigeantacha nó roghnacha a fhormheas le haghaidh criosanna áirithe dá gcríoch.
For infection with Brucella abortus, B. melitensis and B. suis, infection with Mycobacterium tuberculosis complex (Mycobacterium bovis, M. caprae and M. tuberculosis) (MTBC), infection with the rabies virus (RABV), enzootic bovine leukosis (EBL), infectious bovine rhinotracheitis/infectious pustular vulvovaginitis (IBR/IPV), infection with Aujeszky’s disease virus (ADV), bovine viral diarrhoea (BVD) and infection with bluetongue virus (serotypes 1-24) (BTV), several Member States have recently applied to the Commission to have disease-free status granted or compulsory or optional eradication programmes approved for certain zones of their territory.
#2831585
Tar éis don Choimisiún measúnú a dhéanamh, léiríodh go gcomhlíonann an t-iarratas sin na critéir a leagtar síos i gCuid II, Caibidil 2, de Rialachán Tarmligthe (AE) 2020/689 maidir le cláir dhíothaithe le haghaidh IBR/IPV a fhormheas.
Following the assessment by the Commission, that application has been shown to comply with the criteria laid down in Part II, Chapter 2, of Delegated Regulation (EU) 2020/689 for approval of eradication programmes for IBR/IPV.